Guoqing Hou Selected Research

tetrathiomolybdate (ammonium tetrathiomolybdate)

3/2010	Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial.
6/2009	Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate.
3/2009	Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease.
11/2008	Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
8/2008	Tetrathiomolybdate is partially protective against hyperglycemia in rodent models of diabetes.
5/2007	Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
12/2006	Tetrathiomolybdate is effective in a mouse model of arthritis.
12/2006	Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
5/2006	The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
11/2005	Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guoqing Hou Research Topics

Disease

6	Hepatolenticular Degeneration (Wilson's Disease) 06/2009 - 05/2006
5	Neoplasms (Cancer) 10/2021 - 11/2005
3	Inflammation (Inflammations) 01/2021 - 11/2008
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2015 - 01/2014
2	Gastritis 12/2020 - 12/2020
2	Metaplasia 12/2020 - 12/2020
2	Infections 12/2020 - 01/2014
2	Fibrosis (Cirrhosis) 06/2009 - 11/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2009 - 05/2006
2	Arthritis (Polyarthritis) 11/2008 - 12/2006
2	Autoimmune Diseases (Autoimmune Disease) 05/2007 - 05/2006
1	Fatty Liver 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Melanoma (Melanoma, Malignant) 12/2020
1	Stomach Neoplasms (Stomach Cancer) 12/2020
1	Ovarian Neoplasms (Ovarian Cancer) 10/2019
1	Zika Virus Infection 01/2019
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 04/2015
1	Mucositis 01/2014
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 03/2010
1	Huntington Disease (Huntington's Disease) 03/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2008
1	Hepatitis 11/2008
1	Multiple Sclerosis 11/2008
1	Experimental Diabetes Mellitus 08/2008
1	Hyperglycemia 08/2008
1	Experimental Arthritis 12/2006
1	Erythema 12/2006
1	Cardiotoxicity 11/2005

Drug/Important Bio-Agent (IBA)

10	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 03/2010 - 11/2005
8	Pharmaceutical PreparationsIBA 10/2019 - 11/2005
6	CopperIBA 06/2009 - 05/2006
5	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 11/2005
3	CytokinesIBA 12/2020 - 11/2005
3	CollagenIBA 06/2009 - 12/2006
2	MatrinesIBA 10/2021 - 10/2019
2	Vorinostat FDA Link 01/2015 - 01/2014
2	ZincIBA 06/2009 - 12/2006
2	Carbon Tetrachloride (Tetrachloromethane)IBA 06/2009 - 05/2007
2	Concanavalin AIBA 11/2008 - 05/2007
2	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2008 - 05/2007
1	Phosphotransferases (Kinase)IBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	torinIBA 01/2021
1	Dual OxidasesIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	IsoenzymesIBA 01/2021
1	Fenofibrate (CiL)FDA LinkGeneric 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	spasmolytic polypeptideIBA 12/2020
1	InflammasomesIBA 12/2020
1	Messenger RNA (mRNA)IBA 12/2020
1	VaccinesIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2015
1	Pattern Recognition ReceptorsIBA 05/2014
1	EnzymesIBA 01/2014
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2014
1	ElectrolytesIBA 01/2014
1	Hydroxyproline (4 Hydroxyproline)IBA 06/2009
1	Amino Acids FDA Link 06/2009
1	polyglutamineIBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009
1	Huntingtin ProteinIBA 03/2009
1	IonsIBA 03/2009
1	Oxidants (Oxidizing Agents)IBA 11/2008
1	IsoprostanesIBA 11/2008
1	Blood Glucose (Blood Sugar)IBA 08/2008
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2005
1	Interleukin-2 (IL2)IBA 11/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005
1	Troponin IIBA 11/2005
1	Indicators and Reagents (Reagents)IBA 11/2005
1	Oxidoreductases (Dehydrogenase)IBA 11/2005

Therapy/Procedure

5	Therapeutics 03/2010 - 11/2005
1	Drug Therapy (Chemotherapy) 10/2019
1	Cell Transplantation 01/2015
1	Stem Cell Transplantation 01/2014